QMS Medical Allied Services Ltd

QMS Medical Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

QMS Medical Allied Services Ltd

₹ 81.0 -1.94%
22 Jul - close price
Company website NSE - SME: QMSMEDI
About

Incorporated in 2017, QMS Medical Allied Services Ltd is a manufacturer and distributor of medical devices[1]

Key Points

Business Overview:[1]
QMASL does marketing and distribution of medical products and medical education services to clinics, pharma, medical companies and also to individual users. These devices are sold directly in the brand of the manufacturer and are sold under the brand name Q Devices. Company manages the distribution for other brands viz. 3M, Heine, Rossmax, etc.

Website NSE - SM
  • Market Cap ₹ 145 Cr.
  • Current Price ₹ 81.0
  • High / Low ₹ 142 / 72.4
  • Stock P/E 12.0
  • Book Value ₹ 50.3
  • Dividend Yield 0.62 %
  • ROCE 17.4 %
  • ROE 14.4 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2023 Mar 2024 Sep 2024 Dec 2024 Mar 2025
35.24 32.29 37.20 43.87 44.58
30.40 28.34 29.96 36.93 38.21
Operating Profit 4.84 3.95 7.24 6.94 6.37
OPM % 13.73% 12.23% 19.46% 15.82% 14.29%
0.15 0.11 0.33 0.19 1.09
Interest 0.81 0.99 1.07 1.31 1.41
Depreciation 0.88 0.88 0.84 0.86 1.36
Profit before tax 3.30 2.19 5.66 4.96 4.69
Tax % 25.76% 29.68% 25.27% 30.24% 23.24%
2.44 1.54 4.23 3.47 3.60
EPS in Rs 1.37 0.86 1.93 1.64 1.87
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024 Mar 2025
122 156
104 131
Operating Profit 18 25
OPM % 15% 16%
0 2
Interest 3 5
Depreciation 3 4
Profit before tax 12 19
Tax % 26% 27%
9 14
EPS in Rs 5.04 6.77
Dividend Payout % 10% -0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 28%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 34%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -30%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 14%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024 Mar 2025
Equity Capital 18 18
Reserves 61 72
32 51
25 49
Total Liabilities 135 190
26 56
CWIP -0 -0
Investments 2 3
108 131
Total Assets 135 190

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024 Mar 2025
1 20
-3 -45
0 26
Net Cash Flow -1 1

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024 Mar 2025
Debtor Days 124 101
Inventory Days 172 176
Days Payable 90 76
Cash Conversion Cycle 205 201
Working Capital Days 250 226
ROCE % 17%

Shareholding Pattern

Numbers in percentages

Dec 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Jun 2025
73.67% 73.67% 73.67% 73.67% 73.67% 73.67% 73.67%
0.71% 1.21% 1.02% 0.01% 0.01% 0.01% 0.01%
25.62% 25.12% 25.32% 26.33% 26.33% 26.33% 26.33%
No. of Shareholders 9251,0431,2131,5861,6951,5191,489

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls